Downregulation of IRS-1 promotes metastasis of head and neck squamous cell carcinoma

Oncology Reports

Volumn 28, Issue 2, 2012, Pages 659-667

  Luo, Xuan ^a   Fan, Songqing ^b   Huang, Wenbin ^c   Zhai, Sulan ^a   Ma, Zhuo ^a   Li, Ping ^a   Sun, Shi Yong ^d   Wang, Xuerong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

E cadherin; Head and neck squamous cell carcinoma; Insulin receptor substrate 1; Metastasis; miR 9

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; MICRORNA 9; UVOMORULIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RECEPTOR SUBSTRATE 1 GENE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GENE; UPREGULATION;

ADULT; AGED; ANIMALS; CADHERINS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN RECEPTOR SUBSTRATE PROTEINS; LYMPHATIC METASTASIS; MALE; MICE; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; RNA, MESSENGER;

EID: 84863493935     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1846     Document Type: Article

References (40)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Som PM: Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol 158: 961-969, 1992.
3. Muller S, Su L, Tighiouart M, et al: Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation. Cancer 113: 97-107, 2008. (Pubitemid 351976391)
4. Dearth RK, Cui X, Kim HJ, Hadsell DL and Lee AV: Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle 6: 705-713, 2007. (Pubitemid 46535683)
5. Metz HE and Houghton AM: Insulin receptor substrate regulation of phosphoinositide 3-kinase. Clin Cancer Res 17: 206-211, 2011.
6. Chang Q, Li Y, White MF, Fletcher JA and Xiao S: Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res 62: 6035-6038, 2002. (Pubitemid 35244449)
7. Houghton AM, Rzymkiewicz DM, Ji H, et al: Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med 16: 219-223, 2010.
8. Koda M, Sulkowska M, Kanczuga-Koda L and Sulkowski S: Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases. J Clin Pathol 58: 645-649, 2005. (Pubitemid 40814028)
9. Dearth RK, Cui X, Kim HJ, et al: Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol 26: 9302-9314, 2006. (Pubitemid 44904425)
10. Ma Z, Gibson SL, Byrne MA, Zhang J, White MF and Shaw LM: Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis. Mol Cell Biol 26: 9338-9351, 2006. (Pubitemid 44904428)
11. Shi J, Wang DM, Wang CM, et al: Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial-mesenchymal transition. Cancer Res 69: 7180-7187, 2009.
12. Vernon AE and LaBonne C: Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr Biol 14: R719-R721, 2004. (Pubitemid 39290047)
13. Martin A and Cano A: Tumorigenesis: Twist1 links EMT to self-renewal. Nat Cell Biol 12: 924-925, 2010.
14. McCarthy N: Metastasis: Twisting BMI1. Nat Rev Cancer 10: 666, 2010.
15. Peinado H, Olmeda D and Cano A: Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428, 2007. (Pubitemid 46809165)
16. Eulalio A, Huntzinger E and Izaurralde E: Getting to the root of miRNA-mediated gene silencing. Cell 132: 9-14, 2008.
17. Ventura A and Jacks T: MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591, 2009.
18. Croce CM and Calin GA: miRNAs, cancer, and stem cell division. Cell 122: 6-7, 2005. (Pubitemid 40977933)
19. Nicoloso MS, Spizzo R, Shimizu M, Rossi S and Calin GA: MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer 9: 293-302, 2009.
20. Ma L, Young J, Prabhala H, et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256, 2010.
21. Burk U, Schubert J, Wellner U, et al: A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9: 582-589, 2008. (Pubitemid 351772923)
22. Wellner U, Schubert J, Burk UC, et al: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11: 1487-1495, 2009.
23. Zhang X, Su L, Pirani AA, et al: Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis. Clin Exp Metastasis 23: 209-222, 2006. (Pubitemid 44673810)
24. Zhang X, Liu Y, Gilcrease MZ, et al: A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 95: 1663-1672, 2002.
25. Zhang H, Su L, Muller S, et al: Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma. Br J Cancer 99: 1684-1694, 2008.
26. Cantarini MC, de la Monte SM, Pang M, et al: Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology 44: 446-457, 2006. (Pubitemid 44214884)
27. Gregory PA, Bert AG, Paterson EL, et al: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601, 2008. (Pubitemid 351627379)
28. Bazzoni F, Rossato M, Fabbri M, et al: Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci USA 106: 5282-5287, 2009.
29. Dubrovska A, Kim S, Salamone RJ, et al: The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 106: 268-273, 2009.
30. Tiede S, Kloepper JE, Ernst N, Poeggeler B, Kruse C and Paus R: Nestin in human skin: exclusive expression in intramesenchymal skin compartments and regulation by leptin. J Invest Dermatol 129: 2711-2720, 2009.
31. Shao M, Cao L, Shen C, et al: Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase. Cancer Res 69: 9192-9201, 2009.
32. Tsuji S, Hisaoka M, Morimitsu Y, et al: Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcriptionpolymerase chain reaction using archival paraffin-embedded tissues. Am J Pathol 153: 1807-1812, 1998. (Pubitemid 28550668)
33. Chen Z, Zhang K, Zhang X, et al: Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor-environment interaction in metastasis of head and neck squamous cell carcinoma. Clin Exp Metastasis 20: 335-342, 2003. (Pubitemid 36745662)
34. Wan HY, Guo LM, Liu T, Liu M, Li X and Tang H: Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 9: 16, 2010.
35. Garg A and Aggarwal BB: Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 16: 1053-1068, 2002. (Pubitemid 34618844)
36. Barnes CJ, Ohshiro K, Rayala SK, El-Naggar AK and Kumar R: Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Clin Cancer Res 13: 4291-4299, 2007. (Pubitemid 47105993)
37. Forastiere A, Koch W, Trotti A and Sidransky D: Head and neck cancer. N Engl J Med 345: 1890-1900, 2001. (Pubitemid 33716564)
38. Gibson SL, Ma Z and Shaw LM: Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis. Cell Cycle 6: 631-637, 2007. (Pubitemid 46535670)
39. Myatt SS, Wang J, Monteiro LJ, et al: Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 70: 367-377, 2010.
40. Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T and Yuasa Y: MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Cancer 129: 2611-2620, 2011.